#Novo Nordisk

4 articles with this tag

OpenAI buys Orchestra Bio to cut drug timelines
Artificial Intelligence

OpenAI buys Orchestra Bio to cut drug timelines

OpenAI acquired Orchestra Bio to merge its coordination platform with Rosalind, targeting the 10 to 15 year drug development timeline with agents for program management.

15 days ago
AI Accelerates Weight Drug Discovery
Technology

AI Accelerates Weight Drug Discovery

AI is accelerating the development of new weight management drugs like Wegovy, promising faster discovery cycles and personalized therapies.

4 months ago
Funding Round

Dia Beta Labs Raises €1.4M for Diabetes Cell Therapies

Northern Ireland-based biotech startup Dia Beta Labs has secured €1.4 million in funding.

about 1 year ago
Dia Beta Labs Raises €1.4M for Diabetes Cell Therapies
Funding Round

Dia Beta Labs Raises €1.4M for Diabetes Cell Therapies

Dia Beta Labs secured €1.4 million in funding from undisclosed investors. This investment will advance its development of next-generation therapies for obesity and Type 2 diabetes. The company's technology focuses on protecting and repairing insulin-producing beta-cells.

about 1 year ago